DMPA and HIV: do we need a trial?
Westhoff, C.L.; Winikoff, B.
Contraception 90(4): 353
2014
ISSN/ISBN: 1879-0518 PMID: 25183262 DOI: 10.1016/j.contraception.2014.08.008Document Number: 623005
Document emailed within 0-6 h
Related Documents
Laroche, G.; Pezolet, M.; Dufourcq, J.; Dufourc, E.J. 1989: Structure and dynamics of dmpa calcium and dmpa poly l lysine complexes Biophysical Journal 55(2 Part 2): 131ALaroche, G.; Pezolet, M.; Dufourcq, J.; Dufourc, E.J. 1989: Structure and dynamics of dmpa calcium and dmpa poly l lysine complexes Biophysical Journal 55(2 Part 2): 131A
Laroche, G.; Pezolet, M.; Dufourcq, J.; Dufourc, E.J. 1989: Structure and dynamics of dmpa calcium and dmpa poly l lysine complexes Biophysical Journal 55(2 Part 2): 131A
Laroche, G.; Pezolet, M.; Dufourcq, J.; Dufourc, E.J. 1989: Structure and dynamics of dmpa calcium and dmpa poly l lysine complexes Biophysical Journal 55(2 Part 2): 131A
Stout, A.; Wood, S.; Namagembe, A.; Kaboré, A.; Siddo, D.; Ndione, I. 2018: Designing a global monitoring system for pilot introduction of a new contraceptive technology, subcutaneous DMPA (DMPA-SC) Evaluation and Program Planning 68: 185-193
Kaunitz, A.M.; Darney, P.D.; Ross, D.; Wolter, K.D.; Speroff, L. 2009: Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density Contraception 80(1): 7-17
Kaunitz, A.M.; Darney, P.D.; Ross, D.; Wolter, K.D.; Speroff, L. 2009: Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density Contraception 80(1): 7-17
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Zhou, L.; Liu, Y. 2011: The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age Contraception 83(3): 218-222
Gai, L.; Zhang, J.; Zhang, H.; Gai, P.; Zhou, L.; Liu, Y. 2011: The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age Contraception 83(3): 218-222
Burke, H.M.; Chen, M.; Buluzi, M.; Fuchs, R.; Wevill, S.; Venkatasubramanian, L.; Santo, L.D.; Ngwira, B. 2019: Factors Affecting Continued use of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC): a Secondary Analysis of a 1-Year Randomized Trial in Malawi Global Health Science and Practice 7(1): 54-65
Nicoletti, A. 2010: Prescribing DMPA to teens Journal of Pediatric and Adolescent Gynecology 23(4): 259-260
Kaunitz, A.M. 2002: Current concepts regarding use of DMPA Journal of Reproductive Medicine 47(9 Suppl): 785-789
Westhoff, C. 2002: Bone mineral density and DMPA Journal of Reproductive Medicine 47(9 Suppl): 795-799
Shelton, J.D.; Halpern, V. 2014: Subcutaneous DMPA: a better lower dose approach Contraception 89(5): 341-343
Mbuagbaw, L.; Thabane, L.; Ongolo-Zogo, P.; Lang, T. 2011: The challenges and opportunities of conducting a clinical trial in a low resource setting: the case of the Cameroon mobile phone SMS (CAMPS) trial, an investigator initiated trial Trials 12: 145
Nelson, A. 2002: Merits of DMPA relative to other reversible contraceptive methods Journal of Reproductive Medicine 47(9 Suppl): 781-784
Gongsakdi, D.; Rojanasakul, A. 1986: Galactorrhea in DMPA users: incidence and clinical significance Journal of the Medical Association of Thailand 69(1): 28-32
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Lumbiganon, P. 1994: Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary Contraception 49(3): 203-209
Remez, L. 1992: Invasive Cervical Cancer Risk No Greater for DMPA Users Than for Nonusers International Family Planning Perspectives 18(4): 156-157